PHILADELPHIA, June 08, 2022 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in a fireside chat at the Goldman Sachs 43rd Annual Global Healthcare Conference in Rancho Palos Verdes, CA on Wednesday, June 15, 2022 at 11:20 a.m. P.T.

A live audio webcast of the presentation can also be accessed via the investors section of the Amicus Therapeutics corporate website at

https://ir.amicusrx.com/events-and-presentations

.

About Amicus Therapeutics



Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare metabolic diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a robust pipeline of cutting-edge, first- or best-in-class medicines for rare metabolic diseases. For more information please visit the company’s website at

www.amicusrx.com

, and follow us on

Twitter

and

LinkedIn

.

CONTACT:

Investors:


Amicus Therapeutics

Andrew Faughnan

Executive Director, Investor Relations


[email protected]


(609) 662-3809

Media:


Amicus Therapeutics

Diana Moore

Head of Global Corporate Communications


[email protected]


(609) 662-5079

FOLD–G